跳至主要内容
临床试验/NL-OMON55149
NL-OMON55149招募中4 期

Treatment of vascular stiffness in patients with autosomal dominant polycystic kidney disease - TRAMPOLINE

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 54 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Adults with ADPKD diagnosis based on Ravine criteria and/or a documented Pkd
  • 1 or 2 mutation
  • - CKD-EPI eGFR >=60 ml/min/1.73m2
  • - Ability to provide informed consent

排除标准

  • - Uncontrolled hypertension, defined as an office blood pressure of >=160/ >=90
  • mmHg with or without antihypertensive treatment
  • - Concomitant use of >=3 antihypertensive medications
  • - When antihypertensive treatment is prescribed for any other treatment
  • indication than hypertension (e.g. cardia arrhythmia)
  • - Serum potassium levels >5.5 mmol/L (measured within last 6 months)
  • - History of liver disease (excluding liver cysts due to ADPKD)
  • - History of heart failure (cardiac ejection fraction < 35%) or cardiac
  • - History of diabetes mellitus
  • - Active infection or antibiotic therapy
  • - Immunosuppressive therapy within the last year
  • - Concomitant use of drugs that could influence blood pressure and/or disease
  • progression (Tolvaptan/non-steroidal anti-inflammatory drugs
  • (NSAIDs)/chemotherapy), excluding <3 antihypertensive drugs
  • - Actual pregnancy or unwillingness to adhere to reproductive precautions
  • during the duration of the study

研究者

相似试验